Researchers published a dataset covering thousands of methylated sites from hundreds of cancer-derived cultured cells, covering many leukemias, lymphomas and myelomas, from humans and mice. With this data, any researcher can access the epigenetic signature of these tumors for research and clinical purposes. Researchers published a dataset covering thousands of methylated sites from hundreds of cancer-derived cultured cells, covering many leukemias, lymphomas and myelomas, from humans and mice. With this data, any researcher can access the epigenetic signature of these tumors for research and clinical purposes.
